JP Morgan Chase
WVE icon

JP Morgan Chase’s Wave Life Sciences WVE Stock Holding History

JP Morgan Chase’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.44M Sell
670,170
-222,716
-25% -$2.9M ﹤0.01% 3428
2025
Q4 		$15.2M Buy
892,886
+32,745
+4% +$333K ﹤0.01% 2306
2025
Q3 		$6.3M Sell
860,141
-708,874
-45% -$5.74M ﹤0.01% 3151
2025
Q2 		$10.2M Buy
1,569,015
+390,078
+33% +$2.58M ﹤0.01% 2536
2025
Q1 		$9.53M Buy
1,178,937
+474,600
+67% +$5.19M ﹤0.01% 2584
2024
Q4 		$8.71M Buy
704,337
+328,670
+87% +$4.39M ﹤0.01% 2822
2024
Q3 		$3.08M Sell
375,667
-16,382
-4% -$97.9K ﹤0.01% 3625
2024
Q2 		$1.96M Sell
392,049
-63,762
-14% -$364K ﹤0.01% 3809
2024
Q1 		$2.81M Sell
455,811
-6,906
-1% -$34.6K ﹤0.01% 3573
2023
Q4 		$2.34M Buy
462,717
+2,154
+0.5% +$11.5K ﹤0.01% 3716
2023
Q3 		$2.65M Sell
460,563
-15,186
-3% -$69.3K ﹤0.01% 3340
2023
Q2 		$1.73M Buy
475,749
+36,736
+8% +$148K ﹤0.01% 3640
2023
Q1 		$1.9M Sell
439,013
-2,239
-0.5% -$10.3K ﹤0.01% 3579
2022
Q4 		$3.09M Sell
441,252
-3,617
-0.8% -$16.7K ﹤0.01% 3220
2022
Q3 		$1.61M Sell
444,869
-32,241
-7% -$107K ﹤0.01% 3651
2022
Q2 		$1.55M Sell
477,110
-402,528
-46% -$774K ﹤0.01% 3745
2022
Q1 		$1.76M Sell
879,638
-60,503
-6% -$148K ﹤0.01% 3850
2021
Q4 		$2.95M Sell
940,141
-75,006
-7% -$311K ﹤0.01% 3511
2021
Q3 		$4.97M Buy
1,015,147
+102,119
+11% +$619K ﹤0.01% 3026
2021
Q2 		$6.08M Sell
913,028
-372,020
-29% -$2.43M ﹤0.01% 2884
2021
Q1 		$7.21M Buy
1,285,048
+193,572
+18% +$1.86M ﹤0.01% 2650
2020
Q4 		$8.59M Sell
1,091,476
-37,987
-3% -$319K ﹤0.01% 2338
2020
Q3 		$10.4M Buy
1,129,463
+329,986
+41% +$3.62M ﹤0.01% 2011
2020
Q2 		$8.32M Buy
799,477
+18,367
+2% +$173K ﹤0.01% 2047
2020
Q1 		$7.32M Buy
781,110
+501,788
+180% +$4.27M ﹤0.01% 1983
2019
Q4 		$2.24M Buy
279,322
+92,089
+49% +$2.26M ﹤0.01% 3310
2019
Q3 		$3.85M Buy
187,233
+144,994
+343% +$3.32M ﹤0.01% 2908
2019
Q2 		$1.11M Sell
42,239
-86,627
-67% -$2.43M ﹤0.01% 3796
2019
Q1 		$5.01M Buy
128,866
+10,154
+9% +$412K ﹤0.01% 2580
2018
Q4 		$4.99M Sell
118,712
-41,234
-26% -$1.83M ﹤0.01% 2577
2018
Q3 		$8M Buy
159,946
+15,679
+11% +$707K ﹤0.01% 2386
2018
Q2 		$5.52M Sell
144,267
-11,707
-8% -$504K ﹤0.01% 2615
2018
Q1 		$6.25M Sell
155,974
-5,358
-3% -$225K ﹤0.01% 2391
2017
Q4 		$5.66M Buy
161,332
+43,232
+37% +$1.26M ﹤0.01% 2587
2017
Q3 		$2.63M Buy
+118,100
New +$2.37M ﹤0.01% 2994
2017
Q2 		– Sell
-3,947
Closed -$109K – 5257
2017
Q1 		$109K Sell
3,947
-6,639
-63% -$185K ﹤0.01% 4300
2016
Q4 		$277K Buy
+10,586
New +$344K ﹤0.01% 4034

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase's WVE Position: Q1 2026 in Review

JP Morgan Chase reduced its Wave Life Sciences (WVE) stake by 25% in Q1 2026, selling an estimated $2.9M and leaving 670,170 shares worth $4.44M. The position accounts for ﹤0.01% of the portfolio, ranked #3428.

JP Morgan Chase first reported a position in WVE in Q4 2016 and has held it in 37 quarters since. The position peaked at $15.2M in Q4 2025. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • JP Morgan Chase held 670,170 shares of Wave Life Sciences worth $4.44M as of Q1 2026.
  • JP Morgan Chase sold 222,716 Wave Life Sciences shares in Q1 2026, an estimated $2.9M.
  • Wave Life Sciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3428 holding.
  • JP Morgan Chase first reported a position in Wave Life Sciences in Q4 2016 and has held it in 37 quarters since.
  • JP Morgan Chase's Wave Life Sciences position peaked at $15.2M in Q4 2025.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.